Alliance Pharma plc Stock price

Equities

APH

GB0031030819

Pharmaceuticals

Delayed London S.E. 10:03:48 2024-03-28 am EDT 5-day change 1st Jan Change
39.4 GBX -0.25% Intraday chart for Alliance Pharma plc +1.68% -2.72%
Sales 2023 * 183M 231M Sales 2024 * 196M 247M Capitalization 213M 269M
Net income 2023 * 17M 21.43M Net income 2024 * 18M 22.7M EV / Sales 2023 * 1.67 x
Net Debt 2023 * 92.2M 116M Net Debt 2024 * 70.24M 88.56M EV / Sales 2024 * 1.45 x
P/E ratio 2023 *
11.6 x
P/E ratio 2024 *
11.9 x
Employees 285
Yield 2023 *
2.56%
Yield 2024 *
2.63%
Free-Float 88.26%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.30%
1 week-0.41%
Current month-7.34%
1 month-4.59%
3 months+0.37%
6 months-17.89%
Current year-4.71%
More quotes
1 week
37.05
Extreme 37.0451
39.80
1 month
36.00
Extreme 36
44.00
Current year
35.53
Extreme 35.525
46.00
1 year
33.70
Extreme 33.7
73.04
3 years
33.70
Extreme 33.7
123.00
5 years
33.70
Extreme 33.7
123.00
10 years
30.00
Extreme 30
123.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 10-02-21
Director of Finance/CFO 58 15-09-27
Chief Operating Officer - 23-01-31
Members of the board TitleAgeSince
Chief Executive Officer 49 10-02-21
Director/Board Member 55 23-01-31
Director/Board Member 57 18-12-31
More insiders
Date Price Change Volume
24-03-28 39.4 -0.25% 496 961
24-03-27 39.5 +0.89% 1,037,625
24-03-26 39.15 -0.89% 662,130
24-03-25 39.5 +1.28% 859,401
24-03-22 39 +0.65% 885,029

Delayed Quote London S.E., March 28, 2024 at 04:55 am EDT

More quotes
Alliance Pharma PLC is a United Kingdom-based international consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. Its segments are strategic business units that represent different parts of the overall product portfolio, these being Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Changmin, Fazol Cream, Hydromol Ointment, Kelo-Stretch Cream, and others. It holds the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are sold around the world in more than 100 countries.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
0.395 GBP
Average target price
0.6743 GBP
Spread / Average Target
+70.71%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Alliance Pharma plc - London S.E.